Medicare Benefits Schedule - Item 66829

Search Results for Item 66829

View Associated Notes

Category 6 - PATHOLOGY SERVICES

66829

66829 - Additional Information

Item Start Date:
01-Nov-2024
Description Updated:
01-Nov-2024
Schedule Fee Updated:
01-Nov-2024

Group
P2 - Chemical

Quantitation of BNP or NT‑proBNP for the exclusion of a diagnosis of heart failure in a patient presenting in a non‑hospital setting to assist in decision‑making regarding the clinical necessity of an echocardiogram, where heart failure is suspected based on signs and symptoms but diagnosis is uncertain

Applicable once in any 12 month period

Fee: $58.50 Benefit: 75% = $43.90 85% = $49.75

(See para PN.2.6 of explanatory notes to this Category)


Associated Notes

Category 6 - PATHOLOGY SERVICES

PN.2.6

Brain Natriuretic Peptide (BNP) or N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP) testing under MBS item 66829 is intended as a decision aid regarding the clinical necessity of an echocardiogram

BNP or NT-proBNP testing under MBS item 66829 is intended as a decision aid regarding the clinical necessity of an echocardiogram. Where a patient presents with symptoms of suspected but uncertain heart failure, a BNP or NT-proBNP test under MBS item 66829 can be requested where clinically appropriate, in line with guidelines from the National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand.

Related Items: 66829


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change